Chronic Kidney Disease and Cardiovascular Disease: Best Practices to Improve Outcomes

Chronic kidney disease (CKD) and cardiovascular disease (CVD) are serious chronic illnesses, and each have a substantial burden on public health. In most cases, these chronic illnesses do not occur in isolation, and the impact on patient morbidity and mortality is more profound when multiple diseases are present. CVD mortality is a more likely outcome than kidney failure in patients with CKD. This activity will address the association between CKD and CVD. Evaluation and monitoring will also be addressed. Evidence-based management strategies that utilize a multifactorial approach to reducing CVD risk in patients with CKD will also be included.

Learning Objectives: 

After participation in this activity, learners will be better able to:

  • Recognize the link between CKD and CVD, including overlapping risk factors associated with each disease state.
  • Identify risk for CVD in CKD patients to better address patient needs.
  • Examine multiple intervention and risk reduction strategies for CVD to improve outcomes in patients with CKD.

Target Audience

  • Physicians
  • Nurses
  • Pharmacists
  • Physician Assistants
  • Nurse Practitioners
Accreditation/Designation of Credit Statements:

The National Kidney Foundation is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Physician

The National Kidney Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TMPhysicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurse

Awarded 1.0 contact hours of continuing nursing education (includes 0.25 contact hours in the area of pharmacology).

Pharmacist

This application-based enduring activity has been assigned ACPE Universal Activity Number 0620-0000-17-001-H01-P for 1.0 contact hours (0.10 CEUs). The activity is available for credit through February 17, 2018. To receive credit, learners must read the activity overview, learning objectives and faculty disclosures, complete the pre-test, review the content, complete the post-test with a minimum score of 70% (post-test may be taken up to 3 times) and electronic activity evaluation. An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact cmeinfo@kidney.org if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

Physician Assistant 

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hours of Category I credit for completing this program.

The activity is available for credit through February 17, 2018.

Nurse Practitioner

This activity is approved for 1.0 contact hours of continuing education (which includes 0.25 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 17012484.

This activity was planned in accordance with AANP CE Standards and Policies. 

The activity is available for credit through February 17, 2018.

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; and complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit. The estimated time for completion is 1.5 hours. To receive AMA PRA Category 1 Credit(s)™, participants must receive a minimum score of 70% on the post-test.     

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Course summary
Available credit: 
  • 1.00 AANP Contact Hours
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 0.25 AANP Pharmacology
  • 0.25 ANCC Pharmacology
  • 1.00 Attendance
  • 1.00 Category I Credit for Physician Assistants
Course opens: 
02/17/2017
Course expires: 
02/17/2018
Cost:
$0.00
Rating: 
5
Faculty Disclosures:

Peter McCullough, MD
Vice Chief of Medicine
Baylor University Medical Center
Dallas, TX
Disclosure: Has no financial relationships with commercial interest(s).

Matthew R. Weir, MD
Professor and Director, Division of Nephrology
University of Maryland School of Medicine
Baltimore, MD
Disclosure: Received honorarium from MSD, Sanofi, BI, AstraZeneca, and Janssen in the area of diabetes, Akebia in the area of anemia, and Relypsa in the area of hyperkalemia for his role as a Scientific Advisor.

Paul Drawz, MD, MHS, MS
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN
Disclosure: Has no financial relationships with commercial interest(s).

Planning Committee Disclosures:

Sue Cary, MN, RN, ANP-BC, CNN
NP Nephrology
Ochsner Nephrology
Baton Rouge, LA
Disclosure: Has no financial relationships with commercial interest(s).

Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA
Disclosure: Has no financial relationships with commercial interest(s).

Dwayne Allen Pierce, BSPharm, PharmD, BCPS
Pharmacy Clinical Coordinator
University of Kentucky Healthcare
Lexington, KY
Disclosure: Has no financial relationships with commercial interest(s).

James Papanikolaw, MA
Senior Scientific Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Anna Okoniewski
CME/CE Activities Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Anil K. Agarwal, MD
Professor of Medicine
The Ohio State University
Dublin, OH
Disclosure: Is a member of the Advisory Board for Amgen, Alexion, and Hospira; and received a research grant from Merit Medical.

Laly Joseph, DVM, DNP, RN,C, MSN, ARNP, ANP, B.C.
Assistant Professor
University of Miami
Pembroke Pines, FL
Disclosure: Has no financial relationships with commercial interest(s).

Vanessa Bradley, RD
Registered Dietitian
Fresenius Kidney Care
Huntsville, AL
Disclosure: Has no financial relationships with commercial interest(s).

Teresa V. Lewis, PharmD
Assistant Professor
University of Oklahoma College of Pharmacy
Oklahoma City, OK
Disclosure: Has no financial relationships with commercial interest(s).


This activity is supported by an educational grant from AstraZeneca.

Available Credit

  • 1.00 AANP Contact Hours
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 0.25 AANP Pharmacology
  • 0.25 ANCC Pharmacology
  • 1.00 Attendance
  • 1.00 Category I Credit for Physician Assistants

Accreditation Period

Course opens: 
02/17/2017
Course expires: 
02/17/2018

Price

Cost:
$0.00
Please login or register for a PERC account to take this course.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals